ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
151 hedge funds and large institutions have $1B invested in Acorda Therapeutics in 2017 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 74 increasing their positions, 31 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
67% less call options, than puts
Call options by funds: $6.08M | Put options by funds: $18.3M
Holders
151
Holding in Top 10
1
Calls
$6.08M
Puts
$18.3M
Top Buyers
| 1 | +$51M | |
| 2 | +$32.6M | |
| 3 | +$16.8M | |
| 4 |
HEC
Hudson Executive Capital
New York
|
+$15.2M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$12.1M |
Top Sellers
| 1 | -$69.3M | |
| 2 | -$13M | |
| 3 | -$11.7M | |
| 4 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$10.9M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$8.05M |